Precigen, Inc. Common Stock
Here’s whether Precigen, Inc. Common Stock (PGEN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: 50-day MA is rising (+3.96% over 10 days); strong 1-year return of +169.2%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); RSI 28 — oversold; rising volume on a downtrend (distribution, 1.37x avg). Currently 34.5% off its 52-week high. Score: -2/7.
PGEN is trading below its 200-day MA ($4.02) — a key warning sign the longer-term trend is under pressure. An RSI of 27.9 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +169.2% compares to +24.4% for SPY (beat the market by 144.8%). The current 34.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.